2.36 USD
↘ 0.93 (28.30%)AT CLOSE (11:59 AM EDT)
Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares
CANFAMEX • USD
2.40
↗ 0.04 (1.53%)
POST MARKET (AS OF 07:23 PM EDT)
Post Market
AS OF 07:23 PM EDT
2.40
↗ 0.04 (1.53%)
Market: OPEN
Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares (CANF) trades at $2.40 per share. Technical indicators currently signal "Strong Sell". This is driven by a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Sep 2, 2026.
Open?$2.78
High?$2.78
Low?$2.32
Prev. Close?$3.29
Volume?20.3M
Avg. Volume?N/A
VWAP?$3.88
Bid / Ask
Bid?$2.39 × 500
Ask?$2.43 × 300
Spread?$0.04
Midpoint?$2.41
Valuation & Ratios
Market Cap?7.0M
Shares Out?2.1M
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.
Themes
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestLow
Short Interest?61.8K
Days to Cover?1.7
Avg Daily Volume37.2K
Settlement Date2026-08-14